223 related articles for article (PubMed ID: 31101827)
1. Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension.
Weiss A; Neubauer MC; Yerabolu D; Kojonazarov B; Schlueter BC; Neubert L; Jonigk D; Baal N; Ruppert C; Dorfmuller P; Pullamsetti SS; Weissmann N; Ghofrani HA; Grimminger F; Seeger W; Schermuly RT
Nat Commun; 2019 May; 10(1):2204. PubMed ID: 31101827
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension.
Veeroju S; Kojonazarov B; Weiss A; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Novoyatleva T; Schermuly RT
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540939
[TBL] [Abstract][Full Text] [Related]
3. PAR-2 inhibition reverses experimental pulmonary hypertension.
Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
[TBL] [Abstract][Full Text] [Related]
4. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
5. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
6. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
Yamamura A; Nayeem MJ; Sato M
Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
[TBL] [Abstract][Full Text] [Related]
9. Prostanoid EP
Li HH; Hsu HH; Chang GJ; Chen IC; Ho WJ; Hsu PC; Chen WJ; Pang JS; Huang CC; Lai YJ
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L349-L359. PubMed ID: 29146573
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
[TBL] [Abstract][Full Text] [Related]
13. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
14. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
15. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
16. PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension.
Lampron MC; Vitry G; Nadeau V; Grobs Y; Paradis R; Samson N; Tremblay È; Boucherat O; Meloche J; Bonnet S; Provencher S; Potus F; Paulin R
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):783-801. PubMed ID: 31969012
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
[TBL] [Abstract][Full Text] [Related]
18. Osthole inhibits cell proliferation by regulating the TGF-β1/Smad/p38 signaling pathways in pulmonary arterial smooth muscle cells.
Yue Y; Li YQ; Fu S; Wu YT; Zhu L; Hua L; Lv JY; Li YL; Yang DL
Biomed Pharmacother; 2020 Jan; 121():109640. PubMed ID: 31810114
[TBL] [Abstract][Full Text] [Related]
19. LRP1 promotes synthetic phenotype of pulmonary artery smooth muscle cells in pulmonary hypertension.
Zucker MM; Wujak L; Gungl A; Didiasova M; Kosanovic D; Petrovic A; Klepetko W; Schermuly RT; Kwapiszewska G; Schaefer L; Wygrecka M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1604-1616. PubMed ID: 30910704
[TBL] [Abstract][Full Text] [Related]
20. Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
Liu P; Huang W; Ding Y; Wu J; Liang Z; Huang Z; Xie W; Kong H
Drug Des Devel Ther; 2021; 15():1653-1666. PubMed ID: 33935492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]